Impact of ALDH1A1 Expression in Intrahepatic Cholangiocellular Carcinoma
Open Access
- 1 January 2025
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 16 (1) , 1-11
Abstract
Background: Intrahepatic cholangiocarcinoma (iCC) is a rare malignant liver tumor with limited therapeutic advancements. Despite its increasing global incidence knowledge of treatment options remains stagnant, leading to poor five-year patient survival rates and high recurrence post-surgery. ALDH1A1, a member of the ALDH superfamily, is associated with cancer stem cells and has conflicting reports regarding its prognostic role in iCC.Keywords
This publication has 58 references indexed in Scilit:
- Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell PopulationsMolecular Cancer Research, 2008
- Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamilyExpert Opinion on Drug Metabolism & Toxicology, 2008
- ALDH1A1 and ALDH3A1 expression in lung cancers: Correlation with histologic type and potential precursorsLung Cancer, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Liver Fluke Induces CholangiocarcinomaPLOS Medicine, 2007
- Clinical utility of epidermal growth factor receptor expression for selecting patients with advanced non-small cell lung cancer for treatment with erlotinib.2006
- Classification of Sensitivity or Resistance of Cervical Cancers to Ionizing Radiation According to Expression Profiles of 62 Genes Selected by cDNA Microarray AnalysisNeoplasia, 2002
- Heterotypic Signaling between Epithelial Tumor Cells and Fibroblasts in Carcinoma FormationExperimental Cell Research, 2001
- Know thy neighbor: stromal cells can contribute oncogenic signalsCurrent Opinion in Genetics & Development, 2001
- Evidence for a signal peptide at the amino‐terminal end of human mitochondrial aldehyde dehydrogenaseFEBS Letters, 1987